GE
Genovis
Viimeisin kurssi
19,46 SEK
22.7.2026
Viimeisin
30,00 SEK
+54.16%
Nousuvara
GENO
3 kk+54,16%1 kurssitavoitteet
6 kk+54,16%3 kurssitavoitteet
1 v+54,16%3 kurssitavoitteet
Max 4 kurssitavoitteet
Nordea
TerveydenhuoltoBiotechnology
Tietoa yhtiöstä
Genovis was founded in 1999 by Sarah Fredriksson, who was CEO of Genovis until May 2015, when she became chairman of the board. The business was initially focused on nanoparticles intended for both the preclinical and clinical market.
Genovis
